Time course of severe respiratory syncytial virus infection in mechanically ventilated infants

R C Tasker1, I Gordon, K Kiff

  • 1General Paediatric Intensive Care Unit, Great Ormond Street Hospital for Children, London, UK.

Insights

Predicting intensive care duration for infants with respiratory syncytial virus (RSV) is possible. Early mechanical ventilation parameters like alveolar-arterial oxygen gradient (AaDO2) and mean airway pressure (MAP) can indicate prolonged intensive care needs.

Area of Science:

  • Pediatrics
  • Critical Care Medicine
  • Respiratory Medicine

Background:

  • Severe respiratory syncytial virus (RSV) lower respiratory tract illness in infants often requires intensive care and mechanical ventilation.
  • Predicting the duration of intensive care is crucial for resource allocation and evaluating treatment efficacy.

Purpose of the Study:

  • To determine if early gas exchange severity during mechanical ventilation can predict the intensive care course for infants with RSV.
  • To establish clinical criteria for stratifying RSV patients based on predicted intensive care duration.

Main Methods:

  • Retrospective analysis of 45 RSV-infected infants to identify predictive criteria using alveolar-arterial oxygen gradient (AaDO2) and mean airway pressure (MAP).
  • Prospective validation using AaDO2 and MAP criteria in 44 RSV-infected infants to assess length of intensive care stay.
  • Chest X-ray findings (four-quadrant consolidation) were used to assess lower airway disease severity.

Main Results:

  • Early AaDO2 and MAP values during the first 48 hours of mechanical ventilation were associated with disease severity.
  • Specific criteria (e.g., AaDO2 > 400 and MAP > 10 in the first 24h) predicted severe illness with high accuracy.
  • Infants meeting severe criteria had significantly longer intensive care stays (median 17 days) compared to others (median 7 days).

Conclusions:

  • The time course of intensive care for mechanically ventilated infants with RSV is predictable using early respiratory parameters.
  • Alveolar-arterial oxygen gradient and mean airway pressure within the first 48 hours are valuable predictors of intensive care duration.
  • These findings should be considered when interpreting outcomes of therapies measured by intensive care stay in RSV patients.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...